Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review

References

1. 1.↵
   1. Bost C,
   2. Pascual O,
   3. Honnorat J

   . Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat 2016;12:2775–87 doi:10.2147/NDT.S82380 pmid:27822050

   CrossRefPubMed
2. 2.↵
   1. Vollmer TL,
   2. McCarthy M

   . Autoimmune encephalitis: a more treatable tragedy if diagnosed early. Neurology 2016;86:1655–56 doi:10.1212/WNL.0000000000002641 pmid:27037233

   Abstract/FREE Full Text
3. 3.↵
   1. Abboud H,
   2. Probasco JC,
   3. Irani S, et al

   ; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 2021;92:757–68 doi:10.1136/jnnp-2020-325300 pmid:33649022

   Abstract/FREE Full Text
4. 4.↵
   1. Graus F,
   2. Titulaer MJ,
   3. Balu R, et al

   . A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016;15:391–404 doi:10.1016/S1474-4422(15)00401-9 pmid:26906964

   CrossRefPubMed
5. 5.↵
   1. Kalman B

   . Autoimmune encephalitides: a broadening field of treatable conditions. Neurologist 2017;22:1–13 doi:10.1097/NRL.0000000000000087 pmid:28009765

   CrossRefPubMed
6. 6.↵
   1. Sachs JR,
   2. Zapadka ME,
   3. Popli GS, et al

   . Arterial spin labeling perfusion imaging demonstrates cerebral hyperperfusion in anti-NMDAR encephalitis. Radiol Case Rep 2017;12:833–37 doi:10.1016/j.radcr.2017.06.004 pmid:29484082

   CrossRefPubMed
7. 7.↵
   1. Dalmau J,
   2. Lancaster E,
   3. Martinez-Hernandez E, et al

   . Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63–74 doi:10.1016/S1474-4422(10)70253-2 pmid:21163445

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Vallabhaneni D,
   2. Naveed MA,
   3. Mangla R, et al

   . Perfusion imaging in autoimmune encephalitis. Case Rep Radiol 2018;2018:3538645 doi:10.1155/2018/3538645 pmid:29854534

   CrossRefPubMed
9. 9.↵
   1. Llorens V,
   2. Gabilondo I,
   3. Gomez-Esteban JC, et al

   . Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis. J Neurol 2010;257:1568–69 doi:10.1007/s00415-010-5546-z pmid:20352245

   CrossRefPubMed
10. 10.↵
    1. Suárez JP,
    2. Domínguez ML,
    3. Gómez MA, et al

    . Brain perfusion SPECT with ^99mTc-HMPAO in the diagnosis and follow-up of patients with anti-NMDA receptor encephalitis [in English, Spanish]. Neurologia (Engl Ed) 2018;33:622–23 doi:10.1016/j.nrl.2016.05.019 pmid:27452621

    CrossRefPubMed
11. 11.↵
    1. Bordonne M,
    2. Chawki MB,
    3. Doyen M, et al

    . Brain ¹⁸F-FDG PET for the diagnosis of autoimmune encephalitis: a systematic review and a meta-analysis. Eur J Nucl Med Mol Imaging 2021;48:3847–58 doi:10.1007/s00259-021-05299-y pmid:33677643

    CrossRefPubMed
12. 12.↵
    1. Dinoto A,
    2. Cheli M,
    3. Ajčević M, et al

    . ASL MRI and ¹⁸F-FDG-PET in autoimmune limbic encephalitis: clues from two paradigmatic cases. Neurol Sci 2021;42:3423–25 doi:10.1007/s10072-021-05207-0 pmid:33763811

    CrossRefPubMed
13. 13.↵
    1. Li R,
    2. Shi PA,
    3. Liu TF, et al

    . Role of 3D pseudocontinuous arterial spin-labeling perfusion in the diagnosis and follow-up in patients with herpes simplex encephalitis. AJNR Am J Neuroradiol 2019;40:1901–07 doi:10.3174/ajnr.A6279 pmid:31649156

    Abstract/FREE Full Text
14. 14.↵
    1. Solomon TH,
    2. Hart IJ,
    3. Beeching NJ

    . Viral encephalitis: a clinician’s guide. Pract Neurol 2007;7:288–305

    Abstract/FREE Full Text
15. 15.↵
    1. Dubey D,
    2. Pittock SJ,
    3. Kelly CR, et al

    . Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis. Ann Neurol 2018;83:166–77 doi:10.1002/ana.25131 pmid:29293273

    CrossRefPubMed
16. 16.↵
    1. Dubey D,
    2. Singh J,
    3. Britton JW, et al

    . Predictive models in the diagnosis and treatment of autoimmune epilepsy. Epilepsia 2017;58:1181–89 doi:10.1111/epi.13797 pmid:28555833

    CrossRefPubMed
17. 17.↵
    1. Cyril AS,
    2. Nair SS,
    3. Mathai A, et al

    . Autoimmune encephalitis: clinical diagnosis versus antibody confirmation. Ann Indian Acad Neurol 2015;18:408–11 doi:10.4103/0972-2327.165454 pmid:26713011

    CrossRefPubMed
18. 18.↵
    1. Harutyunyan G,
    2. Hauer L,
    3. Dunser MW, et al

    . Autoimmune encephalitis at the neurological intensive care unit: etiologies, reasons for admission and survival. Neurocrit Care 2017;27:82–89 doi:10.1007/s12028-016-0370-7 pmid:28028790

    CrossRefPubMed
19. 19.↵
    1. Morbelli S,
    2. Arbizu J,
    3. Booij J, et al

    ; European Association of Nuclear Medicine (EANM) and of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), The need of standardization and of large clinical studies in an emerging indication of [¹⁸F]FDG PET: the autoimmune encephalitis. Eur J Nucl Med Mol Imaging 2017;44:353–57 doi:10.1007/s00259-016-3589-9 pmid:27924371

    CrossRefPubMed
20. 20.↵
    1. Armangue T,
    2. Leypoldt F,
    3. Dalmau J

    . Autoimmune encephalitis as differential diagnosis of infectious encephalitis. Curr Opin Neurol 2014;27:361–68 doi:10.1097/WCO.0000000000000087 pmid:24792345

    CrossRefPubMed
21. 21.↵
    1. Chow FC,
    2. Glaser CA,
    3. Sheriff H, et al

    . Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics. Clin Infect Dis 2015;60:1377–83 doi:10.1093/cid/civ051 pmid:25637586

    CrossRefPubMed
22. 22.↵
    1. Celicanin M,
    2. Blaabjerg M,
    3. Maersk-Moller C, et al

    . Autoimmune encephalitis associated with voltage-gated potassium channels-complex and leucine-rich glioma-inactivated 1 antibodies: a national cohort study. Eur J Neurol 2017;24:999–1005 doi:10.1111/ene.13324 pmid:28544133

    CrossRefPubMed
23. 23.↵
    1. Deibler AR,
    2. Pollock JM,
    3. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, Part 1: technique and artifacts. AJNR Am J Neuroradiol 2008;29:1228–34 doi:10.3174/ajnr.A1030 pmid:18372417

    CrossRefPubMed
24. 24.↵
    1. Petcharunpaisan S,
    2. Ramalho J,
    3. Castillo M

    . Arterial spin-labeling in neuroimaging. World J Radiol 2010;2:384–98 doi:10.4329/wjr.v2.i10.384 pmid:21161024

    CrossRefPubMed
25. 25.↵
    1. Baumgartner A,
    2. Rauer S,
    3. Mader I, et al

    . Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013;260:2744–53 doi:10.1007/s00415-013-7048-2 pmid:23900756

    CrossRefPubMed
26. 26.↵
    1. Deibler AR,
    2. Pollock JM,
    3. Kraft RA, et al

    . Arterial spin-labeling in routine clinical practice, Part 3: hyperperfusion patterns. AJNR Am J Neuroradiol 2008;29:1428–35 doi:10.3174/ajnr.A1034 pmid:18356466

    CrossRefPubMed
27. 27.↵
    1. Vogrig A,
    2. Joubert B,
    3. Ducray F, et al

    . Glioblastoma as differential diagnosis of autoimmune encephalitis. J Neurol 2018;265:669–77 doi:10.1007/s00415-018-8767-1 pmid:29383516

    CrossRefPubMed
28. 28.↵
    1. Gaxiola-Valdez I,
    2. Singh S,
    3. Perera T, et al

    . Seizure onset zone localization using postictal hypoperfusion detected by arterial spin labelling MRI. Brain 2017;140:2895–911 doi:10.1093/brain/awx241 pmid:29053782

    CrossRefPubMed
29. 29.↵
    1. Lee SM,
    2. Kwon S,
    3. Lee YJ

    . Diagnostic usefulness of arterial spin labeling in MR negative children with new onset seizures. Seizure 2019;65:151–58 doi:10.1016/j.seizure.2019.01.024 pmid:30718217

    CrossRefPubMed
30. 30.↵
    1. Espinosa-Jovel C,
    2. Toledano R,
    3. García-Morales I, et al

    . Serial arterial spin labeling MRI in autonomic status epilepticus due to anti-LGI1 encephalitis. Neurology 2016;87:443–44 doi:10.1212/WNL.0000000000002903 pmid:27462038

    Abstract/FREE Full Text
31. 31.↵
    1. Chen Y,
    2. Xing XW,
    3. Zhang JT, et al

    . Autoimmune encephalitis mimicking sporadic Creutzfeldt-Jakob disease: a retrospective study. J Neuroimmunol 2016;295-296:1–8 doi:10.1016/j.jneuroim.2016.03.012 pmid:27235341

    CrossRefPubMed
32. 32.↵
    1. Maat P,
    2. de Beukelaar JW,
    3. Jansen C, et al

    . Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Neurol Neuroimmunol Neuroinflamm 2015;2:e178 doi:10.1212/NXI.0000000000000178 pmid:26601117

    Abstract/FREE Full Text
33. 33.↵
    1. Yuan J,
    2. Wang S,
    3. Hu W

    . Combined findings of FDG-PET and arterial spin labeling in sporadic Creutzfeldt-Jakob disease. Prion 2018;12:310–14 doi:10.1080/19336896.2018.1525255 pmid:30223705

    CrossRefPubMed
34. 34.↵
    1. Haller S,
    2. Zaharchuk G,
    3. Thomas DL, et al

    . Arterial spin-labeling perfusion of the brain: emerging clinical applications. Radiology 2016;281:337–56 doi:10.1148/radiol.2016150789 pmid:27755938

    CrossRefPubMed
35. 35.↵
    1. Fisher RE,
    2. Patel NR,
    3. Lai EC, et al

    . Two different 18F-FDG brain PET metabolic patterns in autoimmune limbic encephalitis. Clin Nucl Med 2012;37:e213–18 doi:10.1097/RLU.0b013e31824852c7 pmid:22889795

    CrossRefPubMed
36. 36.↵
    1. Lapucci C,
    2. Boffa G,
    3. Massa F, et al

    . Could arterial spin-labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? Eur J Neurol 2019;26:e86–87 doi:10.1111/ene.13977 pmid:31099961

    CrossRefPubMed
37. 37.↵
    1. Li X,
    2. Yuan J,
    3. Liu L, et al

    . Antibody-LGI 1 autoimmune encephalitis manifesting as rapidly progressive dementia and hyponatremia: a case report and literature review. BMC Neurol 2019;19:19 doi:10.1186/s12883-019-1251-4 pmid:30732585

    CrossRefPubMed